首页 > 最新文献

Journal of Gastrointestinal Surgery最新文献

英文 中文
Efficacy evaluation of postoperative adjuvant TACE in preventing HCC recurrence within Milan criteria: A multi-center propensity score matching analysis based on pathological indicators.
IF 2.2 3区 医学 Q3 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2025-02-01 DOI: 10.1016/j.gassur.2025.101978
Kun He, Yongqiang Xiao, Shuju Tu, Yourao Li, Zhao Wu, Liping Liu, Wei Shen, Shiyun Bao, Yongzhu He

Objective: Malignant biological behaviors such as microvascular invasion (MVI), satellite nodule formation and poor differentiation can appear in the postoperative pathology of early hepatocellular carcinoma (HCC), which often indicates that it has entered the stage of malignant evolution earlier. This study aimed to evaluate tumor recurrence in HCC patients meeting the Milan criteria who underwent postoperative adjuvant transarterial chemoembolization (PA-TACE) based on postoperative pathological indices.

Methods: A retrospective study was conducted on 790 HCC patients within the Milan criteria who underwent hepatectomy across four medical centers, comprising 366 patients treated with PA-TACE and 424 patients without PA-TACE. To reduce selection bias, propensity score matching (PSM) at a 1:1 ratio was applied, achieving balanced clinical characteristics between the two groups.

Results: Patients receiving PA-TACE did not experience more severe adverse events or toxicity-related deaths. After PSM of each subgroup, it was found that patients with MVI (Median time: 37 months vs 17 months, p = 0.010), satellite nodules (Median time: NA vs 14 months, p = 0.018), and Edmondson-Steiner grade III-IV (Median time: NA vs 13 months, p = 0.004) who received PA-TACE had higher recurrence-free survival (RFS). However, patients who were MVI-negative, satellite nodule-negative, and Edmondson-Steiner grade I-II did not benefit from PA-TACE in terms of RFS (All p > 0.05). Patients who received PA-TACE were more likely to undergo liver transplantation, re-hepatectomy, and local ablation after tumor recurrence, whereas patients who did not receive PA-TACE were more likely to receive TACE, chemoradiotherapy, and immunotargeted therapy after tumor recurrence (All p < 0.05).

Conclusion: Postoperative pathological indicators can guide the selection of PA-TACE for patients with HCC within the Milan criteria. Patients with MVI, satellite nodules, and Edmondson-Steiner grade III-IV are more suitable for receiving PA-TACE to improve RFS. PA-TACE may alter the recurrence pattern of tumors, rendering them more localized.

{"title":"Efficacy evaluation of postoperative adjuvant TACE in preventing HCC recurrence within Milan criteria: A multi-center propensity score matching analysis based on pathological indicators.","authors":"Kun He, Yongqiang Xiao, Shuju Tu, Yourao Li, Zhao Wu, Liping Liu, Wei Shen, Shiyun Bao, Yongzhu He","doi":"10.1016/j.gassur.2025.101978","DOIUrl":"https://doi.org/10.1016/j.gassur.2025.101978","url":null,"abstract":"<p><strong>Objective: </strong>Malignant biological behaviors such as microvascular invasion (MVI), satellite nodule formation and poor differentiation can appear in the postoperative pathology of early hepatocellular carcinoma (HCC), which often indicates that it has entered the stage of malignant evolution earlier. This study aimed to evaluate tumor recurrence in HCC patients meeting the Milan criteria who underwent postoperative adjuvant transarterial chemoembolization (PA-TACE) based on postoperative pathological indices.</p><p><strong>Methods: </strong>A retrospective study was conducted on 790 HCC patients within the Milan criteria who underwent hepatectomy across four medical centers, comprising 366 patients treated with PA-TACE and 424 patients without PA-TACE. To reduce selection bias, propensity score matching (PSM) at a 1:1 ratio was applied, achieving balanced clinical characteristics between the two groups.</p><p><strong>Results: </strong>Patients receiving PA-TACE did not experience more severe adverse events or toxicity-related deaths. After PSM of each subgroup, it was found that patients with MVI (Median time: 37 months vs 17 months, p = 0.010), satellite nodules (Median time: NA vs 14 months, p = 0.018), and Edmondson-Steiner grade III-IV (Median time: NA vs 13 months, p = 0.004) who received PA-TACE had higher recurrence-free survival (RFS). However, patients who were MVI-negative, satellite nodule-negative, and Edmondson-Steiner grade I-II did not benefit from PA-TACE in terms of RFS (All p > 0.05). Patients who received PA-TACE were more likely to undergo liver transplantation, re-hepatectomy, and local ablation after tumor recurrence, whereas patients who did not receive PA-TACE were more likely to receive TACE, chemoradiotherapy, and immunotargeted therapy after tumor recurrence (All p < 0.05).</p><p><strong>Conclusion: </strong>Postoperative pathological indicators can guide the selection of PA-TACE for patients with HCC within the Milan criteria. Patients with MVI, satellite nodules, and Edmondson-Steiner grade III-IV are more suitable for receiving PA-TACE to improve RFS. PA-TACE may alter the recurrence pattern of tumors, rendering them more localized.</p>","PeriodicalId":15893,"journal":{"name":"Journal of Gastrointestinal Surgery","volume":" ","pages":"101978"},"PeriodicalIF":2.2,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143122999","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Endoluminal approaches for colorectal neoplasia in inflammatory bowel disease: a viable alternative for colectomy? 炎症性肠病结肠直肠肿瘤的腔内治疗方法,结肠切除术的可行替代方案?
IF 2.2 3区 医学 Q3 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2025-02-01 DOI: 10.1016/j.gassur.2024.101876
Ali Alipouriani, Stefan D. Holubar, Kamil Erozkan, Lukas Schabl, Joshua Sommovilla, Michael Valente, Scott R. Steele, Emre Gorgun

Background

Endoscopic resection of visible dysplastic lesions in patients with inflammatory bowel disease (IBD) is an alternative to colectomy. The endoscopic techniques that can be used include endoscopic mucosal resection (EMR), endoscopic submucosal dissection (ESD), and ESD combined with EMR. These endoscopic approaches may allow organ preservation in patients with IBD. This study aimed to evaluate the outcomes of endoscopic resection, including EMR, ESD, and ESD combined with EMR, for the treatment of colorectal dysplasia in patients with IBD.

Methods

This was a retrospective review of patients with IBD who underwent endoscopic resection for colorectal dysplasia at our tertiary care center between 2014 and 2023. Patients were identified via a search of our endoscopy database. Medical records were reviewed to collect data on patient demographics, IBD history, details of endoscopic technique, procedural factors, final pathology results, and outcomes, including recurrence of dysplasia.

Results

A total of 50 patients with IBD who underwent endoscopic resection were included in the study, with 38 ESD cases, 11 ESD combined with EMR cases, and 1 EMR case. The median age was 62 years, (IQR, 54–68), and 34 patients (68%) were male. The median body mass index was 27.6 kg/m2 (IQR, 24.8–31.7). The underlying diagnoses were ulcerative colitis in 33 patients (66%) and Crohn’s disease in 17 patients (33%). The median disease duration was 27.5 years (IQR, 8–30). Polyp locations were distributed as follows: right colon, rectum, left colon, transverse colon, and cecum, with 9 polyps (18%) in each area. The median procedure time was 47.5 min (IQR, 31.2–73.7). En bloc resection was performed in 34 patients (68%), and piecemeal resection was performed in 16 patients (32%). On pathology, the median lesion size was 23.5 mm (IQR, 20.2–40.0). High-grade dysplasia was found in 7 patients (14%), whereas low-grade dysplasia was found in 15 patients (30%). During a median follow-up period of 3 years, 18% of patients experienced recurrence. No significant difference in recurrence rates was observed between the ESD and ESD combined with EMR groups.

Conclusion

Endoscopic resection, including EMR, ESD, and ESD combined with EMR, is an effective treatment of visible dysplastic lesions and is a safe alternative to colectomy in patients with IBD. In this cohort, favorable short-term outcomes were observed after endoscopic resection.
导言:内镜下切除炎症性肠病(IBD)患者可见的发育不良病灶是结肠切除术以外的另一种治疗方法。可采用的内镜技术包括内镜下粘膜切除术(EMR)、内镜下粘膜下剥离术(ESD)以及ESD和EMR的混合方法。这些内镜治疗方法可以保留 IBD 患者的器官。本研究旨在评估内镜下切除术(包括EMR、ESD和ESD/EMR混合术)治疗IBD患者结直肠发育不良的效果:我们对2014年至2023年期间在我们的三级医疗中心接受内镜切除术治疗结直肠发育不良的IBD患者进行了回顾性研究。我们通过搜索内镜数据库确定了患者。对病历进行审查,以收集有关患者人口统计学、IBD病史、内镜技术细节、手术因素、最终病理结果以及包括发育不良复发在内的结果的数据:共有50名IBD患者接受了内镜切除术,包括38例ESD、11例ESD/EMR混合术和1例EMR。中位年龄为 62 岁(IQR:54-68),男性 34 人(68%)。体重指数中位数为 27.6(IQR:24.8-31.7)。33人(66%)被诊断为溃疡性结肠炎,17人(33%)被诊断为克罗恩病。中位病程为 27.5 年(IQR:8-30)。息肉位置分布如下:右结肠、直肠、左结肠、横结肠和盲肠,每个部位有 9 个(18%)。手术时间中位数为 47.5 分钟(IQR:31.2-73.7)。34例(68%)实现了整块切除,16例(32%)实现了分块切除。病理结果显示,中位病灶大小为 23.5 毫米(IQR:20.2-40)。7例(14%)发现高级别发育不良,15例(30%)发现低级别发育不良。在中位 7.2 年的随访期间,18% 的患者复发。ESD组和ESD/EMR组的复发率无明显差异:结论:内镜下切除术,包括EMR、ESD和混合技术,可以有效治疗可见的发育不良病变,作为IBD患者结肠切除术的替代方案。在这组患者中,内镜切除术后的短期疗效良好。
{"title":"Endoluminal approaches for colorectal neoplasia in inflammatory bowel disease: a viable alternative for colectomy?","authors":"Ali Alipouriani,&nbsp;Stefan D. Holubar,&nbsp;Kamil Erozkan,&nbsp;Lukas Schabl,&nbsp;Joshua Sommovilla,&nbsp;Michael Valente,&nbsp;Scott R. Steele,&nbsp;Emre Gorgun","doi":"10.1016/j.gassur.2024.101876","DOIUrl":"10.1016/j.gassur.2024.101876","url":null,"abstract":"<div><h3>Background</h3><div>Endoscopic resection of visible dysplastic lesions in patients with inflammatory bowel disease (IBD) is an alternative to colectomy. The endoscopic techniques that can be used include endoscopic mucosal resection (EMR), endoscopic submucosal dissection (ESD), and ESD combined with EMR. These endoscopic approaches may allow organ preservation in patients with IBD. This study aimed to evaluate the outcomes of endoscopic resection, including EMR, ESD, and ESD combined with EMR, for the treatment of colorectal dysplasia in patients with IBD.</div></div><div><h3>Methods</h3><div>This was a retrospective review of patients with IBD who underwent endoscopic resection for colorectal dysplasia at our tertiary care center between 2014 and 2023. Patients were identified via a search of our endoscopy database. Medical records were reviewed to collect data on patient demographics, IBD history, details of endoscopic technique, procedural factors, final pathology results, and outcomes, including recurrence of dysplasia.</div></div><div><h3>Results</h3><div>A total of 50 patients with IBD who underwent endoscopic resection were included in the study, with 38 ESD cases, 11 ESD combined with EMR cases, and 1 EMR case. The median age was 62 years, (IQR, 54–68), and 34 patients (68%) were male. The median body mass index was 27.6 kg/m<sup>2</sup> (IQR, 24.8–31.7). The underlying diagnoses were ulcerative colitis in 33 patients (66%) and Crohn’s disease in 17 patients (33%). The median disease duration was 27.5 years (IQR, 8–30). Polyp locations were distributed as follows: right colon, rectum, left colon, transverse colon, and cecum, with 9 polyps (18%) in each area. The median procedure time was 47.5 min (IQR, 31.2–73.7). En bloc resection was performed in 34 patients (68%), and piecemeal resection was performed in 16 patients (32%). On pathology, the median lesion size was 23.5 mm (IQR, 20.2–40.0). High-grade dysplasia was found in 7 patients (14%), whereas low-grade dysplasia was found in 15 patients (30%). During a median follow-up period of 3 years, 18% of patients experienced recurrence. No significant difference in recurrence rates was observed between the ESD and ESD combined with EMR groups.</div></div><div><h3>Conclusion</h3><div>Endoscopic resection, including EMR, ESD, and ESD combined with EMR, is an effective treatment of visible dysplastic lesions and is a safe alternative to colectomy in patients with IBD. In this cohort, favorable short-term outcomes were observed after endoscopic resection.</div></div>","PeriodicalId":15893,"journal":{"name":"Journal of Gastrointestinal Surgery","volume":"29 2","pages":"Article 101876"},"PeriodicalIF":2.2,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142621983","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effects of gut microbiota and metabolites on pancreatitis: a 2-sample Mendelian randomization study 肠道微生物群和代谢物对胰腺炎的影响:双样本孟德尔随机研究
IF 2.2 3区 医学 Q3 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2025-02-01 DOI: 10.1016/j.gassur.2024.101885
Zhirong Zhao , Li Han , Baobaonai Tuerxunbieke , Lan Ming , Jiamin Ji , Yuan Chen , Ran Sun , Weiliang Tian , Fan Yang , Qian Huang

Background

Acute pancreatitis (AP) and chronic pancreatitis (CP) have high incidences and poor prognoses. The early screening of at-risk populations still awaits further study. The limitation was mainly based on observational studies, with limited sample size and the presence of confounding factors. This study used a 2-sample Mendelian randomization (MR) analysis based on publicly available data from genome-wide association studies to reveal the causal effect of gut microbiota and metabolites on pancreatitis.

Methods

This study collected summary statistics on gut microbiota, metabolites, AP, and CP. A 2-sample MR analysis was performed using MR-Egger, inverse variance-weighted, MR Pleiotropy RESidual Sum and Outlier, maximum likelihood, and weighted median.

Results

The 2-sample MR showed that only Eubacterium coprostanoligenes was an independent protective factor for AP among all gut microbiota, and the other microbiota were not significant for pancreatitis. Unsaturated fatty acids in metabolites are protective factors for both AP (odds ratio [OR], 0.730; 95% CI, 0.593–0.899; P = .003) and CP (OR, 0.660; 95% CI, 0.457–0.916; P = .013). Furthermore, carnitine was a protective factor CP, and glucose was an independent risk factor for CP.

Conclusion

This study provides potential evidence of the causal role of gut microbiota and metabolites on pancreatitis, which may be conducive for designing microbiome and metabolite interventions on AP or CP in the future.
背景:急性和慢性胰腺炎(AP 和 CP)发病率高、预后差。高危人群的早期筛查仍有待进一步研究。目前的研究主要基于观察性研究,样本量有限且存在混杂因素。我们根据全基因组关联研究(GWAS)的公开数据,采用双样本 MR 分析,揭示肠道微生物群和代谢物对胰腺炎的因果影响:本研究收集了有关肠道微生物群、代谢物、AP 和 CP 的简要统计数据。采用 MR-Egger、逆方差加权(IVW)、MR-PRESSO、最大似然法和加权中位数进行了双样本孟德尔随机分析:结果:双样本孟德尔随机分析表明,在所有肠道微生物群中,只有Eubacterium coprostanoligenes是胰腺炎的独立保护因子,其他微生物群对胰腺炎的影响并不显著。代谢物中的不饱和脂肪酸是胰腺炎(OR=0.730,95% Cl:0.593-0.899,P = 0.003)和胰腺癌(OR=0.660,95% Cl:0.457-0.916,P = 0.013)的保护因素。此外,肉碱是CP的保护因素,但葡萄糖是CP的独立风险因素:本研究首次提供了肠道微生物群和代谢物对胰腺炎的因果作用的潜在证据,这可能有利于在未来的深入研究中设计微生物群和代谢物对 AP 或 CP 的干预措施。
{"title":"Effects of gut microbiota and metabolites on pancreatitis: a 2-sample Mendelian randomization study","authors":"Zhirong Zhao ,&nbsp;Li Han ,&nbsp;Baobaonai Tuerxunbieke ,&nbsp;Lan Ming ,&nbsp;Jiamin Ji ,&nbsp;Yuan Chen ,&nbsp;Ran Sun ,&nbsp;Weiliang Tian ,&nbsp;Fan Yang ,&nbsp;Qian Huang","doi":"10.1016/j.gassur.2024.101885","DOIUrl":"10.1016/j.gassur.2024.101885","url":null,"abstract":"<div><h3>Background</h3><div>Acute pancreatitis (AP) and chronic pancreatitis (CP) have high incidences and poor prognoses. The early screening of at-risk populations still awaits further study. The limitation was mainly based on observational studies, with limited sample size and the presence of confounding factors. This study used a 2-sample Mendelian randomization (MR) analysis based on publicly available data from genome-wide association studies to reveal the causal effect of gut microbiota and metabolites on pancreatitis.</div></div><div><h3>Methods</h3><div>This study collected summary statistics on gut microbiota, metabolites, AP, and CP. A 2-sample MR analysis was performed using MR-Egger, inverse variance-weighted, MR Pleiotropy RESidual Sum and Outlier, maximum likelihood, and weighted median.</div></div><div><h3>Results</h3><div>The 2-sample MR showed that only <em>Eubacterium coprostanoligenes</em> was an independent protective factor for AP among all gut microbiota, and the other microbiota were not significant for pancreatitis. Unsaturated fatty acids in metabolites are protective factors for both AP (odds ratio [OR], 0.730; 95% CI, 0.593–0.899; <em>P</em> = .003) and CP (OR, 0.660; 95% CI, 0.457–0.916; <em>P</em> = .013). Furthermore, carnitine was a protective factor CP, and glucose was an independent risk factor for CP.</div></div><div><h3>Conclusion</h3><div>This study provides potential evidence of the causal role of gut microbiota and metabolites on pancreatitis, which may be conducive for designing microbiome and metabolite interventions on AP or CP in the future.</div></div>","PeriodicalId":15893,"journal":{"name":"Journal of Gastrointestinal Surgery","volume":"29 2","pages":"Article 101885"},"PeriodicalIF":2.2,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142644075","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Long-term follow-up of sacrococcygeal pilonidal sinus disease after previous abscess drainage: a retrospective cohort study 脓肿引流术后骶尾部乳头窦疾病的长期随访;一项回顾性队列研究。
IF 2.2 3区 医学 Q3 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2025-02-01 DOI: 10.1016/j.gassur.2024.101892
Jochem de Kort , Anne Akke Pronk , Menno R. Vriens , Niels Smakman , Edgar J.B. Furnee
{"title":"Long-term follow-up of sacrococcygeal pilonidal sinus disease after previous abscess drainage: a retrospective cohort study","authors":"Jochem de Kort ,&nbsp;Anne Akke Pronk ,&nbsp;Menno R. Vriens ,&nbsp;Niels Smakman ,&nbsp;Edgar J.B. Furnee","doi":"10.1016/j.gassur.2024.101892","DOIUrl":"10.1016/j.gassur.2024.101892","url":null,"abstract":"","PeriodicalId":15893,"journal":{"name":"Journal of Gastrointestinal Surgery","volume":"29 2","pages":"Article 101892"},"PeriodicalIF":2.2,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142687262","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Postoperative skeletal muscle loss as a prognostic indicator of clinical outcomes in patients with gastric cancer: a systematic review and meta-analysis 术后骨骼肌损失作为胃癌患者临床预后的预后指标:一项系统综述和荟萃分析
IF 2.2 3区 医学 Q3 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2025-02-01 DOI: 10.1016/j.gassur.2024.101898
Chenyang Zhan , Jun Bu , Sheng Li , Xiujin Huang , Zongjie Quan

Background

A decrease in skeletal muscle mass is frequently observed during the perioperative period in patients with gastric cancer (GC) and is strongly associated with postoperative complications and poor long-term survival outcomes. Relevant research indicates that a certain proportion of patients with GC experience skeletal muscle mass loss after surgery. Therefore, a systematic review and meta-analysis was conducted to assess postoperative skeletal muscle loss as a prognostic marker for clinical outcomes in patients with GC.

Methods

PubMed, Web of Science, and Embase were used to systematically screen and retrieve relevant studies according to strictly established inclusion and exclusion criteria. Further analysis of the effect of postoperative skeletal muscle loss on long-term survival metrics (including overall survival [OS], recurrence-free survival [RFS], disease-free survival [DFS], and disease-specific survival [DSS]) in patients with GC was performed.

Results’

From 10 studies and 11 related publications, more than 3764 patients with GC were identified. Severe postoperative skeletal muscle loss occurred in 25.7% of patients with GC and was significantly correlated with poorer OS (hazard ratio [HR], 2.27; 95% CI, 1.58–3.25; P <.00001), RFS (HR, 2.96; 95% CI, 1.47–5.97; P =.002), DFS (HR, 2.41; 95% CI, 1.17–4.97; P =.02), and DSS (HR, 4.12; 95% CI, 2.44–6.94; P <.00001). When postoperative skeletal muscle loss advanced to sarcopenia, patients had worse OS as well (HR, 2.22; 95% CI, 1.49–3.30; P <.0001).

Conclusion

Patients who undergo radical surgery for GC often experience skeletal muscle mass loss, and significant skeletal muscle mass loss is associated with poorer survival outcomes. Identifying patients with significant skeletal muscle mass loss during follow-up and promptly providing tailored interventions, such as nutritional and exercise support, are essential.
目的:在胃癌(GC)患者围手术期经常观察到骨骼肌质量的减少,并与术后并发症和不良的长期生存结果密切相关。相关研究表明,有一定比例的胃癌患者术后出现骨骼肌质量下降。因此,我们进行了一项系统回顾和荟萃分析,以评估术后骨骼肌损失作为胃癌患者临床结局的预后指标。方法:采用PubMed、Web of Science和Embase数据库,按照严格制定的纳入和排除标准,系统筛选和检索相关研究。我们进一步分析了术后骨骼肌损失对胃癌患者长期生存指标(包括总生存期(OS)、无复发生存期(RFS)、无病生存期(DFS)、疾病特异性生存期(DSS))的影响。结果:从10项研究和11篇相关出版物中,确定了超过3764例GC患者。25.7%的GC患者发生严重的术后骨骼肌损失,并与较差的OS (HR=2.27, 95%CI, 1.58-3.25, p < 0.00001)、RFS (HR=2.96, 95%CI, 1.47-5.97, p=0.002)、DFS (HR=2.41, 95%CI, 1.17-4.97, p=0.02)、DSS (HR=4.12, 95%CI, 2.44-6.94, p < 0.00001)显著相关。当术后骨骼肌损失进展为肌肉减少时,患者的OS也更差(HR=2.22, 95%CI, 1.49 ~ 3.30, p < 0.0001)。结论:接受胃癌根治性手术的患者经常出现骨骼肌质量下降,而骨骼肌质量明显下降与较差的生存结果有关。在随访期间确定骨骼肌质量明显下降的患者,并及时提供量身定制的干预措施,如营养和运动支持,是至关重要的。
{"title":"Postoperative skeletal muscle loss as a prognostic indicator of clinical outcomes in patients with gastric cancer: a systematic review and meta-analysis","authors":"Chenyang Zhan ,&nbsp;Jun Bu ,&nbsp;Sheng Li ,&nbsp;Xiujin Huang ,&nbsp;Zongjie Quan","doi":"10.1016/j.gassur.2024.101898","DOIUrl":"10.1016/j.gassur.2024.101898","url":null,"abstract":"<div><h3>Background</h3><div>A decrease in skeletal muscle mass is frequently observed during the perioperative period in patients with gastric cancer (GC) and is strongly associated with postoperative complications and poor long-term survival outcomes. Relevant research indicates that a certain proportion of patients with GC experience skeletal muscle mass loss after surgery. Therefore, a systematic review and meta-analysis was conducted to assess postoperative skeletal muscle loss as a prognostic marker for clinical outcomes in patients with GC.</div></div><div><h3>Methods</h3><div>PubMed, Web of Science, and Embase were used to systematically screen and retrieve relevant studies according to strictly established inclusion and exclusion criteria. Further analysis of the effect of postoperative skeletal muscle loss on long-term survival metrics (including overall survival [OS], recurrence-free survival [RFS], disease-free survival [DFS], and disease-specific survival [DSS]) in patients with GC was performed.</div></div><div><h3>Results’</h3><div>From 10 studies and 11 related publications, more than 3764 patients with GC were identified. Severe postoperative skeletal muscle loss occurred in 25.7% of patients with GC and was significantly correlated with poorer OS (hazard ratio [HR], 2.27; 95% CI, 1.58–3.25; <em>P</em> &lt;.00001), RFS (HR, 2.96; 95% CI, 1.47–5.97; <em>P</em> =.002), DFS (HR, 2.41; 95% CI, 1.17–4.97; <em>P</em> =.02), and DSS (HR, 4.12; 95% CI, 2.44–6.94; <em>P</em> &lt;.00001). When postoperative skeletal muscle loss advanced to sarcopenia, patients had worse OS as well (HR, 2.22; 95% CI, 1.49–3.30; <em>P</em> &lt;.0001).</div></div><div><h3>Conclusion</h3><div>Patients who undergo radical surgery for GC often experience skeletal muscle mass loss, and significant skeletal muscle mass loss is associated with poorer survival outcomes. Identifying patients with significant skeletal muscle mass loss during follow-up and promptly providing tailored interventions, such as nutritional and exercise support, are essential.</div></div>","PeriodicalId":15893,"journal":{"name":"Journal of Gastrointestinal Surgery","volume":"29 2","pages":"Article 101898"},"PeriodicalIF":2.2,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142750974","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Analyzing the interaction between time to surgery and tumor burden score in hepatocellular carcinoma 肝细胞癌手术时间与肿瘤负荷评分的相互作用分析。
IF 2.2 3区 医学 Q3 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2025-02-01 DOI: 10.1016/j.gassur.2024.101903
Miho Akabane , Jun Kawashima , Selamawit Woldesenbet , Abdullah Altaf , François Cauchy , Federico Aucejo , Irinel Popescu , Minoru Kitago , Guillaume Martel , Francesca Ratti , Luca Aldrighetti , George A. Poultsides , Yuki Imaoka , Andrea Ruzzenente , Itaru Endo , Ana Gleisner , Hugo P. Marques , Vincent Lam , Tom Hugh , Nazim Bhimani , Timothy M. Pawlik

Background

The effect of “time to surgery (TTS)” on outcomes for curative-intent hepatectomy of hepatocellular carcinoma (HCC) remains debated. The interaction between tumor burden score (TBS) and TTS remains unclear. We sought to evaluate the effects of TBS and TTS on long-term HCC outcomes.

Methods

Patients with HCC who underwent curative-intent hepatectomy (2000–2022) were analyzed from a multi-institutional database and categorized by TTS (≤60 or >60 days). Overall survival (OS) and cancer-specific survival were assessed.

Results

Among 910 patients, median TTS estimates were 22 days in the short TTS group (n = 485) and 120 days in the long TTS group (n = 425). Patients with long TTS were older and were more likely to have American Society of Anesthesiologists class >2, diabetes mellitus, and cirrhosis. There was no difference in median TBS among patients who had short versus long TTS (4.61 vs 5.00, respectively). In addition, there was no difference in 5-year OS (70.0% vs 63.1%, respectively; P =.05). On multivariate analysis TBS (hazard ratio [HR], 1.07; 95% CI, 1.03–1.11; P <.001), log alpha-fetoprotein (HR, 1.08; 95% CI, 1.01–1.14; P =.02), and albumin-bilirubin score (HR, 2.52; 95% CI, 1.66–3.82; P <.001) were associated with OS. In contrast, TTS was not associated with OS (HR, 1.18; 95% CI, 0.78–1.77; P =.43). Interaction analysis demonstrated that TBS was asssociated with OS among patients with short TTS (HR, 1.12; 95% CI, 1.07–1.17; P <.001), but not among patients with long TTS (HR, 0.98; 95% CI, 0.91–1.05; P =.56). Among patients with low TBS (≤5), higher mortality was observed with long TTS versus short TTS (5-year OS: 82.4% vs 63.0%, respectively; P =.001); however, TTS was not associated with OS among patients with high TBS (5-year OS: 57.9% vs 63.3%, respectively; P =.92). Multivariate analysis demonstrated that long TTS was a risk factor for OS among patients with low TBS (HR, 3.12; 95% CI, 1.60–6.01; P <.001), but not among individuals with high TBS (HR, 0.57; 95% CI, 0.30–1.07; P =.08). Similar trends were observed relative to cancer-specific survival.

Conclusion

TTS needs to be considered in light of patient and tumor-specific factors. Expediting TTS may be particularly important among patients with HCC and a low TBS.
背景:“手术时间(TTS)”对肝细胞癌(HCC)治疗目的肝切除术结果的影响存在争议。肿瘤负荷评分(Tumor Burden Score, TBS)与TTS之间的相互作用尚不清楚。本研究评估TBS和TTS如何影响HCC的长期预后。方法:从多机构数据库中分析2000-2022年接受治愈性肝切除术的HCC患者,并按TTS(≤或≤60天)进行分类。评估总生存期(OS)和癌症特异性生存期。结果:910例患者中,短TTS组(n=485)中位TTS为22天,长TTS组(n=425)中位TTS为120天。长期TTS组年龄较大,ASA >2级、糖尿病和肝硬化的发生率较高。中位TBS组间差异无统计学意义(4.61vs5.00)。5年OS差异无统计学意义(70.0%vs63.1%, P=0.05)。多变量分析确定TBS (HR:1.07[1.03-1.11])。结论:术前优化是必要的,减少TTS可能改善低TBS队列的预后。
{"title":"Analyzing the interaction between time to surgery and tumor burden score in hepatocellular carcinoma","authors":"Miho Akabane ,&nbsp;Jun Kawashima ,&nbsp;Selamawit Woldesenbet ,&nbsp;Abdullah Altaf ,&nbsp;François Cauchy ,&nbsp;Federico Aucejo ,&nbsp;Irinel Popescu ,&nbsp;Minoru Kitago ,&nbsp;Guillaume Martel ,&nbsp;Francesca Ratti ,&nbsp;Luca Aldrighetti ,&nbsp;George A. Poultsides ,&nbsp;Yuki Imaoka ,&nbsp;Andrea Ruzzenente ,&nbsp;Itaru Endo ,&nbsp;Ana Gleisner ,&nbsp;Hugo P. Marques ,&nbsp;Vincent Lam ,&nbsp;Tom Hugh ,&nbsp;Nazim Bhimani ,&nbsp;Timothy M. Pawlik","doi":"10.1016/j.gassur.2024.101903","DOIUrl":"10.1016/j.gassur.2024.101903","url":null,"abstract":"<div><h3>Background</h3><div>The effect of “time to surgery (TTS)” on outcomes for curative-intent hepatectomy of hepatocellular carcinoma (HCC) remains debated. The interaction between tumor burden score (TBS) and TTS remains unclear. We sought to evaluate the effects of TBS and TTS on long-term HCC outcomes.</div></div><div><h3>Methods</h3><div>Patients with HCC who underwent curative-intent hepatectomy (2000–2022) were analyzed from a multi-institutional database and categorized by TTS (≤60 or &gt;60 days). Overall survival (OS) and cancer-specific survival were assessed.</div></div><div><h3>Results</h3><div>Among 910 patients, median TTS estimates were 22 days in the short TTS group (n = 485) and 120 days in the long TTS group (n = 425). Patients with long TTS were older and were more likely to have American Society of Anesthesiologists class &gt;2, diabetes mellitus, and cirrhosis. There was no difference in median TBS among patients who had short versus long TTS (4.61 vs 5.00, respectively). In addition, there was no difference in 5-year OS (70.0% vs 63.1%, respectively; <em>P</em> =.05). On multivariate analysis TBS (hazard ratio [HR], 1.07; 95% CI, 1.03–1.11; <em>P</em> &lt;.001), log alpha-fetoprotein (HR, 1.08; 95% CI, 1.01–1.14; <em>P</em> =.02), and albumin-bilirubin score (HR, 2.52; 95% CI, 1.66–3.82; <em>P</em> &lt;.001) were associated with OS. In contrast, TTS was not associated with OS (HR, 1.18; 95% CI, 0.78–1.77; <em>P</em> =.43). Interaction analysis demonstrated that TBS was asssociated with OS among patients with short TTS (HR, 1.12; 95% CI, 1.07–1.17; <em>P</em> &lt;.001), but not among patients with long TTS (HR, 0.98; 95% CI, 0.91–1.05; <em>P</em> =.56). Among patients with low TBS (≤5), higher mortality was observed with long TTS versus short TTS (5-year OS: 82.4% vs 63.0%, respectively; <em>P</em> =.001); however, TTS was not associated with OS among patients with high TBS (5-year OS: 57.9% vs 63.3%, respectively; <em>P</em> =.92). Multivariate analysis demonstrated that long TTS was a risk factor for OS among patients with low TBS (HR, 3.12; 95% CI, 1.60–6.01; <em>P</em> &lt;.001), but not among individuals with high TBS (HR, 0.57; 95% CI, 0.30–1.07; <em>P</em> =.08). Similar trends were observed relative to cancer-specific survival.</div></div><div><h3>Conclusion</h3><div>TTS needs to be considered in light of patient and tumor-specific factors. Expediting TTS may be particularly important among patients with HCC and a low TBS.</div></div>","PeriodicalId":15893,"journal":{"name":"Journal of Gastrointestinal Surgery","volume":"29 2","pages":"Article 101903"},"PeriodicalIF":2.2,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142755024","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Letter to editor regarding: “Impact of splenectomy on long-term outcomes after gastrectomy for gastric cancer: a population-based study” 致编辑关于:“脾切除术对胃癌胃切除术后长期预后的影响:一项基于人群的研究”。
IF 2.2 3区 医学 Q3 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2025-02-01 DOI: 10.1016/j.gassur.2024.101921
Liqiu Kou , Jixuan Wu , Zili Zhang , Lei Zhang
{"title":"Letter to editor regarding: “Impact of splenectomy on long-term outcomes after gastrectomy for gastric cancer: a population-based study”","authors":"Liqiu Kou ,&nbsp;Jixuan Wu ,&nbsp;Zili Zhang ,&nbsp;Lei Zhang","doi":"10.1016/j.gassur.2024.101921","DOIUrl":"10.1016/j.gassur.2024.101921","url":null,"abstract":"","PeriodicalId":15893,"journal":{"name":"Journal of Gastrointestinal Surgery","volume":"29 2","pages":"Article 101921"},"PeriodicalIF":2.2,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142769517","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Endoscopic “step-up” myotomy: a salvage technique for full-thickness tunnel entry in end-stage achalasia 内窥镜 "阶梯式 "肌切开术:终末期尿崩症全厚隧道入口的挽救技术。
IF 2.2 3区 医学 Q3 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2025-02-01 DOI: 10.1016/j.gassur.2024.101895
Jeong Hoon Kim, Qais Dawod, Kartik Sampath
{"title":"Endoscopic “step-up” myotomy: a salvage technique for full-thickness tunnel entry in end-stage achalasia","authors":"Jeong Hoon Kim,&nbsp;Qais Dawod,&nbsp;Kartik Sampath","doi":"10.1016/j.gassur.2024.101895","DOIUrl":"10.1016/j.gassur.2024.101895","url":null,"abstract":"","PeriodicalId":15893,"journal":{"name":"Journal of Gastrointestinal Surgery","volume":"29 2","pages":"Article 101895"},"PeriodicalIF":2.2,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142693046","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Letter to the editor regarding “Graft choice in pancreatectomy with vascular resection: equivalent safety in selected patients” 致编辑的信:“胰腺切除术与血管切除术中的移植物选择:在选定的患者中具有同等的安全性”。
IF 2.2 3区 医学 Q3 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2025-02-01 DOI: 10.1016/j.gassur.2024.101922
Uday Singh Dadhwal
{"title":"Letter to the editor regarding “Graft choice in pancreatectomy with vascular resection: equivalent safety in selected patients”","authors":"Uday Singh Dadhwal","doi":"10.1016/j.gassur.2024.101922","DOIUrl":"10.1016/j.gassur.2024.101922","url":null,"abstract":"","PeriodicalId":15893,"journal":{"name":"Journal of Gastrointestinal Surgery","volume":"29 2","pages":"Article 101922"},"PeriodicalIF":2.2,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142785715","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Invited commentary on exploring rural-urban differences in the receipt of nonelective cancer-specific gastrointestinal surgery using a multilevel mixed-effects approach 特邀评论:利用多层次混合效应方法探索非选择性癌症特异性胃肠道手术的城乡差异。
IF 2.2 3区 医学 Q3 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2025-02-01 DOI: 10.1016/j.gassur.2024.101902
Lena Egbert, Zhi Ven Fong
{"title":"Invited commentary on exploring rural-urban differences in the receipt of nonelective cancer-specific gastrointestinal surgery using a multilevel mixed-effects approach","authors":"Lena Egbert,&nbsp;Zhi Ven Fong","doi":"10.1016/j.gassur.2024.101902","DOIUrl":"10.1016/j.gassur.2024.101902","url":null,"abstract":"","PeriodicalId":15893,"journal":{"name":"Journal of Gastrointestinal Surgery","volume":"29 2","pages":"Article 101902"},"PeriodicalIF":2.2,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142769584","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Journal of Gastrointestinal Surgery
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1